<code id='ACFB6819C8'></code><style id='ACFB6819C8'></style>
    • <acronym id='ACFB6819C8'></acronym>
      <center id='ACFB6819C8'><center id='ACFB6819C8'><tfoot id='ACFB6819C8'></tfoot></center><abbr id='ACFB6819C8'><dir id='ACFB6819C8'><tfoot id='ACFB6819C8'></tfoot><noframes id='ACFB6819C8'>

    • <optgroup id='ACFB6819C8'><strike id='ACFB6819C8'><sup id='ACFB6819C8'></sup></strike><code id='ACFB6819C8'></code></optgroup>
        1. <b id='ACFB6819C8'><label id='ACFB6819C8'><select id='ACFB6819C8'><dt id='ACFB6819C8'><span id='ACFB6819C8'></span></dt></select></label></b><u id='ACFB6819C8'></u>
          <i id='ACFB6819C8'><strike id='ACFB6819C8'><tt id='ACFB6819C8'><pre id='ACFB6819C8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:3663
          An eye emerges from lines of binary codes — health tech coverage from STAT
          Adobe

          Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

          Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

          advertisement

          Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Amid AI frenzy, a top HHS official's quest to create safeguards

          MickyTripathiOfficeoftheNationalCoordinatorforHealthInformationTechnologyMickyTripathiisequalpartsex